Gliknik receives $15M payment from Pfizer after reaching clinical milestone - Baltimore


Feb. 19, 2019 1:26 pm

Gliknik receives $15M payment from Pfizer after reaching clinical milestone

The University of Maryland BioPark company's candidate drug is being developed to treat a rare neurological disorder.

Baltimore's BioPark is part of the University System of Maryland.

(Courtesy photo)

Baltimore biopharmaceutical startup Gliknik said human trials began for a candidate drug it’s developing to treat a rare neurological disorder.

With the beginning of the Phase I clinical trial, the University of Maryland BioPark-based company received a $15 million payment from pharmaceutical giant Pfizer. The payment is tied to a licensing deal between the company and Pfizer, which was initially inked in 2013.

Gliknik is developing a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP), which the company said is not derived from blood. It’s designed to meet the effectiveness of a blood product called Intravenous Immune Globulin, which is used to treat autoimmune diseases. Previously, the candidate received orphan drug designation from the U.S. Food and Drug Administration in 2015.

“Beginning the Phase I clinical trial is an important milestone in the development of this drug candidate,” said Gliknik CEO David S. Block in a statement. “We are hopeful that Pfizer’s clinical development efforts will lead to more treatment options for patients with CIDP.”

Under the licensing deal, Pfizer could also receive royalties on sales if the products are commercialized.

Companies: Gliknik, Pfizer
Already a member? Sign in here
Connect with companies from the community
New call-to-action


Protenus raises $17M in Series C funding round

AKUA enters Silicon Valley logistics and supply chain accelerator

NextStep Robotics receives $1M through NIH agreement



Verizon is looking for the brightest ideas on how to use its 5G technology

Baltimore, MD

Agora Financial

Sr. Frontend Developer

Apply Now
Baltimore, MD 21201

14 West

Junior Database Administrator

Apply Now
Baltimore, MD


Account Executive (Baltimore)

Apply Now releases data behind malicious ads

Frederick-based RoosterBio raises $15M Series B

BurnAlong adds digital connection to the local American Heart Association’s CycleNation event



Escape the August heat with cool AI tech

Baltimore, MD

14 West

Product Operations Manager

Apply Now
Philadelphia OR Baltimore

Technically Media Editorial Intern (Fall 2019)

Apply Now


Business Development Manager

Apply Now

Sign-up for daily news updates from Baltimore

Do NOT follow this link or you will be banned from the site!